2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid

C117H108N16O12 — CID 160667033

IUPAC2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid
SMILESCC(C)(C(=O)O)c1cccc(-c2ccc3c(c2)C(=O)N(c2cccc(-c4nccn4C4CC4)n2)C3)c1.CC(C)n1ccnc1-c1cccc(N2Cc3ccc(-c4cccc(C(C)(C)C(=O)O)c4)cc3C2=O)n1.CC(C)n1ccnc1-c1cccc(N2Cc3ccc(-c4cccc(C5(C(=O)O)CC5)c4)cc3C2=O)n1.COC(=O)C(C)(C)c1cccc(-c2ccc3c(c2)C(=O)N(c2cccc(-c4nccn4C4CC4)n2)C3)c1
InChIInChI=1S/C30H28N4O3.2C29H26N4O3.C29H28N4O3/c1-30(2,29(36)37-3)22-7-4-6-19(16-22)20-10-11-21-18-34(28(35)24(21)17-20)26-9-5-8-25(32-26)27-31-14-15-33(27)23-12-13-23;1-29(2,28(35)36)21-6-3-5-18(15-21)19-9-10-20-17-33(27(34)23(20)16-19)25-8-4-7-24(31-25)26-30-13-14-32(26)22-11-12-22;1-18(2)32-14-13-30-26(32)24-7-4-8-25(31-24)33-17-21-10-9-20(16-23(21)27(33)34)19-5-3-6-22(15-19)29(11-12-29)28(35)36;1-18(2)32-14-13-30-26(32)24-9-6-10-25(31-24)33-17-21-12-11-20(16-23(21)27(33)34)19-7-5-8-22(15-19)29(3,4)28(35)36/h4-11,14-17,23H,12-13,18H2,1-3H3;3-10,13-16,22H,11-12,17H2,1-2H3,(H,35,36);3-10,13-16,18H,11-12,17H2,1-2H3,(H,35,36);5-16,18H,17H2,1-4H3,(H,35,36)
InChIKeyRMLBIJNJTORUGL-UHFFFAOYSA-N
MW1930.25 g/mol
LogP22.21
Rot. Bonds24

About 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid

2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid (PubChem CID 160667033) has the molecular formula C117H108N16O12 and a molecular weight of 1930.25 g/mol. Its IUPAC name is 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid.

Molecular Properties

Compound Name2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid
PubChem CID160667033
Molecular FormulaC117H108N16O12
Molecular Weight1930.25 g/mol
Exact Mass1928.83
IUPAC Name2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid
SMILESCC(C)(C(=O)O)c1cccc(-c2ccc3c(c2)C(=O)N(c2cccc(-c4nccn4C4CC4)n2)C3)c1.CC(C)n1ccnc1-c1cccc(N2Cc3ccc(-c4cccc(C(C)(C)C(=O)O)c4)cc3C2=O)n1.CC(C)n1ccnc1-c1cccc(N2Cc3ccc(-c4cccc(C5(C(=O)O)CC5)c4)cc3C2=O)n1.COC(=O)C(C)(C)c1cccc(-c2ccc3c(c2)C(=O)N(c2cccc(-c4nccn4C4CC4)n2)C3)c1
InChIInChI=1S/C30H28N4O3.2C29H26N4O3.C29H28N4O3/c1-30(2,29(36)37-3)22-7-4-6-19(16-22)20-10-11-21-18-34(28(35)24(21)17-20)26-9-5-8-25(32-26)27-31-14-15-33(27)23-12-13-23;1-29(2,28(35)36)21-6-3-5-18(15-21)19-9-10-20-17-33(27(34)23(20)16-19)25-8-4-7-24(31-25)26-30-13-14-32(26)22-11-12-22;1-18(2)32-14-13-30-26(32)24-7-4-8-25(31-24)33-17-21-10-9-20(16-23(21)27(33)34)19-5-3-6-22(15-19)29(11-12-29)28(35)36;1-18(2)32-14-13-30-26(32)24-9-6-10-25(31-24)33-17-21-12-11-20(16-23(21)27(33)34)19-7-5-8-22(15-19)29(3,4)28(35)36/h4-11,14-17,23H,12-13,18H2,1-3H3;3-10,13-16,22H,11-12,17H2,1-2H3,(H,35,36);3-10,13-16,18H,11-12,17H2,1-2H3,(H,35,36);5-16,18H,17H2,1-4H3,(H,35,36)
InChIKeyRMLBIJNJTORUGL-UHFFFAOYSA-N
XLogP22.21
TPSA342.28 Ų
H-Bond Donors3
H-Bond Acceptors21
Rotatable Bonds24
Heavy Atoms145
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001930.25
LogP ≤ 522.21
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1021

Analyze 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid?
The IUPAC name of 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid (CID 160667033) is 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid.
What is the SMILES notation for 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid?
The canonical SMILES for 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid is CC(C)(C(=O)O)c1cccc(-c2ccc3c(c2)C(=O)N(c2cccc(-c4nccn4C4CC4)n2)C3)c1.CC(C)n1ccnc1-c1cccc(N2Cc3ccc(-c4cccc(C(C)(C)C(=O)O)c4)cc3C2=O)n1.CC(C)n1ccnc1-c1cccc(N2Cc3ccc(-c4cccc(C5(C(=O)O)CC5)c4)cc3C2=O)n1.COC(=O)C(C)(C)c1cccc(-c2ccc3c(c2)C(=O)N(c2cccc(-c4nccn4C4CC4)n2)C3)c1.
What is the InChIKey of 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid?
The InChIKey is RMLBIJNJTORUGL-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H28N4O3.2C29H26N4O3.C29H28N4O3/c1-30(2,29(36)37-3)22-7-4-6-19(16-22)20-10-11-21-18-34(28(35)24(21)17-20)26-9-5-8-25(32-26)27-31-14-15-33(27)23-12-13-23;1-29(2,28(35)36)21-6-3-5-18(15-21)19-9-10-20-17-33(27(34)23(20)16-19)25-8-4-7-24(31-25)26-30-13-14-32(26)22-11-12-22;1-18(2)32-14-13-30-26(32)24-7-4-8-25(31-24)33-17-21-10-9-20(16-23(21)27(33)34)19-5-3-6-22(15-19)29(11-12-29)28(35)36;1-18(2)32-14-13-30-26(32)24-9-6-10-25(31-24)33-17-21-12-11-20(16-23(21)27(33)34)19-7-5-8-22(15-19)29(3,4)28(35)36/h4-11,14-17,23H,12-13,18H2,1-3H3;3-10,13-16,22H,11-12,17H2,1-2H3,(H,35,36);3-10,13-16,18H,11-12,17H2,1-2H3,(H,35,36);5-16,18H,17H2,1-4H3,(H,35,36).
What are the key properties of 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid?
2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid has a molecular weight of 1930.25 g/mol, XLogP of 22.21, 24 rotatable bonds, 3 hydrogen bond donors, and 21 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoic acid;methyl 2-[3-[2-[6-(1-cyclopropylimidazol-2-yl)-2-pyridinyl]-3-oxo-1H-isoindol-5-yl]phenyl]-2-methylpropanoate;2-methyl-2-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]propanoic acid;1-[3-[3-oxo-2-[6-(1-propan-2-ylimidazol-2-yl)-2-pyridinyl]-1H-isoindol-5-yl]phenyl]cyclopropane-1-carboxylic acid is sourced from PubChem (CID 160667033), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).